Surenano Science Initiates FDA Stage GLP Toxicology And Pharmacology Studies For GLP GEP-44 And Enters Discussions To Acquire Ibogaine Formulation IP Portfolio April 24, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1111027620/Surenano-Science-Initiates-FDA-Stage-GLP-Toxicology-And-Pharmacology-Studies-For-GLP-GEP-44-And-Enters-Discussions-To-Acquire-Ibogaine-Formulation-IP-Portfolio
